PharVision Advisers’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-18,122
Closed -$358K 115
2025
Q4
$358K Buy
+18,122
New +$326K 0.18% 178

Other funds holding ALHC

PharVision Advisers's ALHC Position: Q1 2026 in Review

PharVision Advisers sold out of Alignment Healthcare (ALHC) in Q1 2026, closing a stake of 18,122 shares — an estimated $358K sold.

PharVision Advisers first reported a position in ALHC in Q4 2025 and held it in 1 quarter. The position peaked at $358K in Q4 2025. 293 funds tracked by Wall St. Rank hold ALHC as of Q1 2026.

  • PharVision Advisers reported no remaining Alignment Healthcare position as of Q1 2026 after selling out during the quarter.
  • PharVision Advisers sold 18,122 Alignment Healthcare shares in Q1 2026, an estimated $358K.
  • PharVision Advisers first reported a position in Alignment Healthcare in Q4 2025 and held it in 1 quarter.
  • PharVision Advisers's Alignment Healthcare position peaked at $358K in Q4 2025.
  • 293 funds tracked by Wall St. Rank held Alignment Healthcare as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.